Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|BIOLOGICAL: Pertuzumab|DRUG: docetaxel|DRUG: carboplatin|DRUG: doxorubicin|DRUG: cyclophosphamide|DRUG: paclitaxel|DRUG: Bevacizumab
Sponsor: Case Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)